Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 4
2005 2
2006 2
2007 6
2008 3
2009 5
2010 2
2011 4
2012 3
2013 5
2014 2
2015 4
2016 6
2017 3
2018 3
2019 6
2020 11
2021 15
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Intravital three-dimensional bioprinting.
Urciuolo A, Poli I, Brandolino L, Raffa P, Scattolini V, Laterza C, Giobbe GG, Zambaiti E, Selmin G, Magnussen M, Brigo L, De Coppi P, Salmaso S, Giomo M, Elvassore N. Urciuolo A, et al. Among authors: salmaso s. Nat Biomed Eng. 2020 Sep;4(9):901-915. doi: 10.1038/s41551-020-0568-z. Epub 2020 Jun 22. Nat Biomed Eng. 2020. PMID: 32572195
From Conventional Therapies to Immunotherapy: Melanoma Treatment in Review.
Kuryk L, Bertinato L, Staniszewska M, Pancer K, Wieczorek M, Salmaso S, Caliceti P, Garofalo M. Kuryk L, et al. Among authors: salmaso s. Cancers (Basel). 2020 Oct 20;12(10):3057. doi: 10.3390/cancers12103057. Cancers (Basel). 2020. PMID: 33092131 Free PMC article. Review.
Nanotechnologies in protein delivery.
Salmaso S, Bersani S, Semenzato A, Caliceti P. Salmaso S, et al. J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):2736-53. doi: 10.1166/jnn.2006.456. J Nanosci Nanotechnol. 2006. PMID: 17048478 Review.
Physical PEGylation to Prevent Insulin Fibrillation.
Mastrotto F, Bellato F, Andretto V, Malfanti A, Garofalo M, Salmaso S, Caliceti P. Mastrotto F, et al. Among authors: salmaso s. J Pharm Sci. 2020 Jan;109(1):900-910. doi: 10.1016/j.xphs.2019.10.020. Epub 2019 Oct 19. J Pharm Sci. 2020. PMID: 31639392
Novel Oligo-Guanidyl-PEG Carrier Forming Rod-Shaped Polyplexes.
Malfanti A, Mastrotto F, Han Y, Král P, Balasso A, Scomparin A, Pozzi S, Satchi-Fainaro R, Salmaso S, Caliceti P. Malfanti A, et al. Among authors: salmaso s. Mol Pharm. 2019 Apr 1;16(4):1678-1693. doi: 10.1021/acs.molpharmaceut.9b00014. Epub 2019 Mar 21. Mol Pharm. 2019. PMID: 30860853
Nanotechnologies in cancer.
De Rosa G, Caraglia M, Salmaso S, Elbayoumi T. De Rosa G, et al. Among authors: salmaso s. J Drug Deliv. 2013;2013:604293. doi: 10.1155/2013/604293. Epub 2013 May 13. J Drug Deliv. 2013. PMID: 23738075 Free PMC article. No abstract available.
Pullulan Based Bioconjugates for Ocular Dexamethasone Delivery.
Kicková E, Salmaso S, Mastrotto F, Caliceti P, Urtti A. Kicková E, et al. Among authors: salmaso s. Pharmaceutics. 2021 May 26;13(6):791. doi: 10.3390/pharmaceutics13060791. Pharmaceutics. 2021. PMID: 34073275 Free PMC article.
Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model.
Garofalo M, Wieczorek M, Anders I, Staniszewska M, Lazniewski M, Prygiel M, Zasada AA, Szczepińska T, Plewczynski D, Salmaso S, Caliceti P, Cerullo V, Alemany R, Rinner B, Pancer K, Kuryk L. Garofalo M, et al. Among authors: salmaso s. Front Oncol. 2023 Nov 20;13:1259314. doi: 10.3389/fonc.2023.1259314. eCollection 2023. Front Oncol. 2023. PMID: 38053658 Free PMC article.
84 results